Revvity | PKI - Umsatzkosten





Umsatzkosten Veränderung Datum
Agilent USD 836M 9M 2026-06
Align Technology USD 298.76M 4.74M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Celltrion KRW 92.83B 14.59B 2026-03
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Illumina USD 389M 19M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.7B 97.8M 2026-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
OraSure Technologies USD 15.43M 113K 2025-12
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pharma Mar EUR 4.73M 1.08M 2026-06
Qiagen NV USD 196.45M 13.73M 2026-06
Quest Diagnostics USD 2.05B 64M 2026-06
Quidel USD 407M 486.5M 2026-06
Repligen USD 94.09M 8.12M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Waters USD 1.16B 430M 2026-06
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03